News Headlines Article

FDA credibility hurting due to budget issues, commissioner says
Modern Healthcare

Federal budget cuts and budget uncertainty are hurting the credibility of the Food and Drug Administration, agency Commissioner Dr. Margaret Hamburg said Tuesday.

At a conference hosted by Bloomberg Government, Hamburg said the stakeholders regulated by the FDA expect predictability and transparency in how the agency conducts its oversight. And that’s been hard to deliver given the continuing federal budget wars.